CollPlant Biotechnologies Ltd.
CLGN
$0.42
$0.013.38%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | -136.63% | -158.80% | |
| Total Depreciation and Amortization | -- | -- | -5.81% | -2.88% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -- | -19.77% | -18.70% | |
| Change in Net Operating Assets | -- | -- | -143.87% | 446.77% | |
| Cash from Operations | -- | -- | -410.06% | -244.69% | |
| Capital Expenditure | -- | -- | 49.37% | 35.47% | |
| Sale of Property, Plant, and Equipment | -- | -- | -98.53% | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | 78.89% | -252.63% | |
| Cash from Investing | -- | -- | 53.37% | 21.60% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -- | -99.19% | -99.40% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -- | -- | -99.19% | -99.40% | |
| Foreign Exchange rate Adjustments | -- | -- | 62.53% | 99.38% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -- | -362.85% | -260.77% | |